日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phosphorylation of KIAA1429 promotes oxaliplatin resistance through activating the FZD7-Wnt signaling in BRAF(V600E)-mutated colorectal cancer.

KIAA1429 的磷酸化通过激活 BRAF(V600E) 突变结直肠癌中的 FZD7-Wnt 信号通路促进奥沙利铂耐药性

Wan Taixuan, He Minyi, Liu Zhanzhen, Zhou Yihang, Zhou Yebohao, Xiao Wei, Xie Hao, Luo Shuangling, Zheng Haoqi, Kang Liang, Shi Yunxing, Huang Liang

USP14-mediated metabolic competition impairs CD8+ T cell immunosurveillance in hepatocellular carcinoma

USP14介导的代谢竞争会损害肝细胞癌中CD8+ T细胞的免疫监视功能。

Yuan, Yichuan; Niu, Yi; Huang, Zhenkun; Shi, Yunxing; Lin, Zhu; Zuo, Dinglan; Zhong, Chengrui; Li, Kai; Guan, Xin-Yuan; Yuan, Yunfei; Li, Binkui

Regulatory factor X1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by transcriptional regulation of BECN1.

调控因子 X1 通过转录调控 BECN1 促进索拉非尼诱导的肝细胞癌铁死亡

Yang Zhiwen, Yuan Yichuan, Niu Yi, Zuo Dinglan, Liu Wenwu, Li Kai, Shi Yunxing, Qiu Zhiyu, Li Keren, Lin Zhu, Zhong Chengrui, Huang Zhenkun, He Wei, Guan Xinyuan, Yuan Yunfei, Zeng Weian, Qiu Jiliang, Li Binkui

Transanal endoscopic local resection versus radical excision in the treatment of massive rectal gastrointestinal stromal tumors: striving for therapeutic advantages

经肛门内镜局部切除术与根治性切除术治疗巨大直肠胃肠道间质瘤:力求获得最佳治疗效果

Wan, Taixuan; Xiao, Jingkun; Zhang, Xingwei; Shi, Yunxing; Xie, Hao; Ye, Fujin; Zheng, Haoqi; Zhou, Yihang; Liu, Zhanzheng; Kang, Liang; Huang, Liang

m(6)A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma

m(6)A介导的lnc-OXAR通过增强Ku70稳定性促进非酒精性脂肪性肝炎相关肝细胞癌的奥沙利铂耐药性

Lin, Zhu; Huang, Zhenkun; Qiu, Jiliang; Shi, Yunxing; Zuo, Dinglan; Qiu, Zhiyu; He, Wei; Niu, Yi; Yuan, Yunfei; Li, Binkui

Watch-and-wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma: a propensity score-matching comparative study

对于最初无法切除的肝细胞癌患者,在转化治疗后获得放射学完全缓解,观察等待策略与手术切除策略的比较:一项倾向评分匹配的比较研究

Li, Binkui; Wang, Chenwei; He, Wei; Qiu, Jiliang; Zheng, Yun; Zou, Ruhai; Lin, Zhu; Shi, Yunxing; Yuan, Yichuan; Zhang, Rong; Zhang, Chao; Chen, Minshan; Lau, Wan Yee; Yuan, Yunfei

Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma

肝细胞癌中m6A修饰在免疫浸润、代谢和耐药性中的综合分析

Shi, Yunxing; Li, Kai; Yuan, Yichuan; Wang, Chenwei; Yang, Zhiwen; Zuo, Dinglan; Niu, Yi; Qiu, Jiliang; Li, Binkui; Yuan, Yunfei; He, Wei

TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study

TACE-HAIC联合靶向治疗和免疫治疗与单纯TACE治疗伴门静脉癌栓的肝细胞癌:一项倾向评分匹配研究

Yuan, Yichuan; He, Wei; Yang, Zhiwen; Qiu, Jiliang; Huang, Zhenkun; Shi, Yunxing; Lin, Zhu; Zheng, Yun; Chen, Minshan; Lau, Wan Yee; Li, Binkui; Yuan, Yunfei

A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinoma

一种基于新型NHEJ基因特征的肝细胞癌风险分层和预后预测模型

Lin, Zhu; Huang, Zhenkun; Shi, Yunxing; Yuan, Yichuan; Niu, Yi; Li, Binkui; Yuan, Yunfei; Qiu, Jiliang

Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma

更正:Elafin 通过与肝细胞癌中的 EGFR 结合,促进肿瘤转移并减弱厄洛替尼的抗转移作用

Wang, Chenwei; Liao, Yadi; He, Wei; Zhang, Hong; Zuo, Dinglan; Liu, Wenwu; Yang, Zhiwen; Qiu, Jiliang; Yuan, Yichuan; Li, Kai; Zhang, Yuanping; Wang, Yongjin; Shi, Yunxing; Qiu, Yuxiong; Gao, Song; Yuan, Yunfei; Li, Binkui